Evidence map›Paper›PMID 32642585›Full record

ArticleHeliyon2020

Awareness, attitudes and practices of women in relation to breast cancer in Niger.

Aissami Abdou, Guido Van Hal, Issimouha Dille

Abstract read
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aissami AbdouDepartment of Epidemiology and Social Medicine, University of Antwerp, Belgium.
Guido Van HalDepartment of Epidemiology and Social Medicine, University of Antwerp, Belgium.
Issimouha DilleSurgical Oncology, Niamey National Reference Hospital, Niamey, Niger.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn Niger, breast cancer is the first cancer related morbidity and mortality within female population. While awareness can contribute to early diagnosis and disease mortality reduction, Niger women's knowledge of breast cancer is not well documented. In this study, we assessed the awareness, attitudes and practices of women in relation to breast cancer and identify the factors associated with it.

methodsThe study was conducted through a cross sectional survey in Zinder and Niamey regions. A random sampling was used to select women in households within health districts. We defined a breast cancer knowledge score and used a generalized linear model to assess factors associated with it.

resultsOverall women's knowledge of breast cancer was found to be low, only 41.2% (37.5-45.0) were aware of breast cancer. 65.0% (61.3-68.7) of women demonstrated an awareness of symptoms. Insufficient level of knowledge was observed on knowledge of risk and protection factors with 27.4 % (24.0-31.0), breast cancer good practice with 16.9% (14.2-19.7). Age OR = 0.98 (0.96-0.99), practicing clinical breast examination OR = 2.25 (1.31-3.16), breastfeeding 3.34 (2.12-5.26), not having a history of participation in breast cancer screening and living in rural and peri-urban areas were found to be associated with awareness of breast cancer.

conclusionNiger women were found to have a relatively low level of breast cancer awareness. While not acquainted with self and clinical breast examination, Niger women knowledge of breast cancer symptoms was acceptable. Awareness programs can promote clinical breast examination as mammography is not common and promote early detection procedures.

Indexed as

AwarenessBreast cancerEarly detectionHealth sciencesKAP-StudyNigerSocial sciences

Identifiers

PMID32642585
PMCPMC7334422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.